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Spontaneous T cell responses against tumors occur fre-
quently. However, the mechanisms by which innate
immune responses become induced in response to can-
cer, and how they can bridge to T cell priming against
tumor antigens, have been poorly understood. We
recently showed that CD11c+ cells produce IFN-b after
tumor implantation and this IFN-b plays a critical role
in cross-priming of endogenous anti-tumor CD8+
T cells in vivo. Using knockout mice lacking candidate
innate immune sensing molecules known to be able to
induce type I IFN production in APCs, we have identi-
fied a critical role for the host STING pathway in tumor
recognition, spontaneous T cell priming, and tumor con-
trol in vivo. As STING has been implicated in cytosolic
DNA sensing, these results implied that tumor-derived
DNA might be the critical ligand for effective innate
immune activation. Therefore, we questioned whether
tumor-derived DNA might be transferred to host APCs
in vivo and lead to STING pathway activation and IFN-b
production. To test this notion, three complementary
methods were employed. Tumor cells were stained either
with the DNA intercalating dye DRAQ5 or the nucleo-
tide analogue Edu and injected into mice. After one day,
tumor-infiltrating CD45+CD11c+ cells were analyzed by
ImageStream single cell cytometry. In fact, a major frac-
tion of host DCs appeared to acquire tumor-derived
DNA using these methods. As a third approach, we uti-
lized a human melanoma xenograft model that allowed
interrogation of host DCs for the presence of human
DNA sequences using species-specific PCR. This strategy
also allowed assessment of both mitochondrial DNA and
genomic DNA. Tumors were implanted and DCs were
highly purified by flow cytometric sorting. Interestingly,
human mitochondrial DNA was clearly detected in
sorted mouse CD45+CD11c+ cells. However, human
genomic DNA sequences were not detected. To further
investigate whether mitochondria transfer actually
occurred, we specifically labeled mitochondria in
B16 melanoma using viral transduction to express a
mitochondria-specific protein conjugated with GFP and
transplanted these tumors into mice. In fact, GFP trans-
fer was detected in the host APCs in a morphology that
resembled whole mitochondria. The host CD11c+ cells
also showed phospho-IRF3 induction and IFN-b produc-
tion ex vivo. Our data suggest that tumor-derived mito-
chondrial DNA can be transferred to host APCs in vivo
and may serve as the major ligand for STING pathway
activation, IFN-b production, and subsequent T cell acti-
vation against tumors.
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